Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence-Reference-Cited by-同舟云学术

Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence

Published:2013-11-17 Issue:12 Volume:19 Page:1625-1631
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kottke Timothy,Boisgerault Nicolas^ORCID,Diaz Rosa Maria,Donnelly Oliver^ORCID,Rommelfanger-Konkol Diana,Pulido Jose,Thompson Jill,Mukhopadhyay Debabrata,Kaspar Roger,Coffey Matt,Pandha Hardev,Melcher Alan,Harrington Kevin,Selby Peter,Vile Richard

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3397.pdf

Reference54 articles.

1. Aguirre-Ghiso, J.A. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834–846 (2007).

2. Goss, P.E. & Chambers, A.F. Does tumour dormancy offer a therapeutic target? Nat. Rev. Cancer 10, 871–877 (2010).

3. Hensel, J.A., Flaig, T.W. & Theodorescu, D. Clinical opportunities and challenges in targeting tumour dormancy. Nat. Rev. Clin. Oncol. 10, 41–51 (2013).

4. McGowan, P.M., Kirstein, J.M. & Chambers, A.F. Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches. Future Oncol. 5, 1083–1098 (2009).

5. Pantel, K., Alix-Panabieres, C. & Riethdorf, S. Cancer micrometastases. Nat. Rev. Clin. Oncol. 6, 339–351 (2009).

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma;Materials Today Bio;2024-10

2. Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses;Molecular Therapy - Oncolytics;2023-06

3. Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells;Cell Communication and Signaling;2023-03-13

4. Antineoplastic agents in chemotherapy facilitating tumor growth and angiogenesis in the interval administrations;Life Sciences;2022-12

5. Systems Biology and Genomics;Holland‐Frei Cancer Medicine;2022-10-21